Dual effects of endothelin-1 (1-31): Induction of mesangial cell migration and facilitation of monocyte recruitment through monocyte chemoattractant protein-1 production by mesangial cells

Hypertension Research

Volumn 27, Issue 6, 2004, Pages 433-440

  Ishizawa, Keisuke ^a   Yoshizumi, Masanori ^a   Tsuchiya, Koichiro ^a   Houchi, Hitoshi ^a   Minakuchi, Kazuo ^a   Izawa, Yuki ^a   Kanematsu, Yasuhisa ^a   Kagami, Shoji ^a   Hirose, Masao ^b   Tamaki, Toshiaki ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b NARUTO UNIVERSITY OF EDUCATION   (Japan)

Author keywords

Endothelin 1 (1 31); Migration; Monocyte chemoattractant protein 1; Rat mesangial cells; THP 1 cells

Indexed keywords

ANGIOTENSIN; CHYMASE; CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ENDOTHELIN 1 [1-31]; ENDOTHELIN 1 DERIVATIVE; ENDOTHELIN A RECEPTOR; ENDOTHELIN A RECEPTOR ANTAGONIST; ENDOTHELIN B RECEPTOR; ENDOTHELIN B RECEPTOR ANTAGONIST; MONOCYTE CHEMOTACTIC PROTEIN 1; N (2,6 DIMETHYLPIPERIDINOCARBONYL) 4 METHYLLEUCYL DEXTRO (1 METHOXYCARBONYLTRYPTOPHANYL) DEXTRO NORLEUCINE; NEUTRALIZING ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; CELL INTERACTION; CELL LYSATE; CELL MIGRATION; CELL STIMULATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CULTURE MEDIUM; GLOMERULONEPHRITIS; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; MESANGIUM CELL; MONONUCLEAR CELL; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RAT; WESTERN BLOTTING;

ANIMALS; ANTIBODIES; ANTIHYPERTENSIVE AGENTS; CELL MOVEMENT; CELLS, CULTURED; CHEMOKINE CCL2; CULTURE MEDIA, CONDITIONED; ENDOTHELIN-1; GLOMERULAR MESANGIUM; PEPTIDE FRAGMENTS; PEPTIDES, CYCLIC; RATS; RATS, SPRAGUE-DAWLEY;

EID: 3242878432     PISSN: 09169636     EISSN: None     Source Type: Journal    
DOI: 10.1291/hypres.27.433     Document Type: Article

References (52)

1. Foidart J, Sraer J, Delarue F, Mahieu P, Ardaillou R: Evidence for mesangial glomerular receptors for angiotensin II linked to mesangial cell contractility. FEBS Lett 1980; 121: 333-339.
2. Jard S, Lombard C, Marie J, Devilliers G: Vasopressin receptors from cultured mesangial cells resemble V1a type. Am J Physiol 1987; 253: F41-F49.
3. + exchange, c-fos expression, and mitogenesis in rat mesangial cells. J Clin Invest 1989; 83: 708-712.
4. Ballermann BJ, Hoover RL, Karnovsky MJ, Brenner BM: Physiologic regulation of atrial natriuretic peptide receptors in rat renal glomeruli. J Clin Invest 1985; 76: 2049-2056.
5. Yanagisawa M, Kurihara H, Kimura S, et al: A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988; 332: 411-415.
6. Simonson MS, Dunn MJ: Endothelin-1 stimulates contraction of rat glomerular mesangial cells and potentiates beta-adrenergic-mediated cyclic adenosine monophosphate accumulation. J Clin Invest 1990; 85: 790-797.
7. Lopez-Farre A, Gomez-Garre D, Bernabeu F, Montanes I, Millas I, Lopez-Novoa JM: Renal effects and mesangial cell contraction induced by endothelin are mediated by PAF. Kidney Int 1991; 39: 624-630.
8. Gomez-Garre D, Ruiz-Ortega M, Ortego M, et al: Effects and interactions of endothelin-1 and angiotensin II on matrix protein expression and synthesis and mesangial cell growth. Hypertension 1996; 27: 885-892.
9. Whiteside C, Munk S, Zhou X, Miralem T, Templeton DM: Chelation of intracellular calcium prevents mesangial cell proliferative responsiveness. J Am Soc Nephrol 1998; 9: 14-25.
10. Yoshimura A, Iwasaki S, Inui K, et al: Endothelin-1 and endothelin B type receptor are induced in mesangial proliferative nephritis in the rat. Kidney Int 1995; 48: 1290-1297.
11. Chen Y, Sun Y, Lin J, Zhou A, Wang H: Research on the mechanism of endothelin inflammatory effects on human mesangial cells. Chin Med J (Engl) 1997; 110: 530-534.
12. Shimada K, Takahashi M, Tanzawa K: Cloning and functional expression of endothelin-converting enzyme from rat endothelial cells. J Biol Chem 1994; 269: 18275-18278.
13. Nakano A, Kishi F, Minami K, Wakabayashi H, Nakaya Y, Kido H: Selective conversion of big endothelins to tracheal smooth muscle-constricting 31 -amino acid-length endothelins by chymase from human mast cells. J Immunol 1997; 159:1987-1992.
14. Yoshizumi M, Kagami S, Suzaki Y, et al: Effect of endothelin-1 (1-31) on human mesangial cell proliferation. Jpn J Pharmacol 2000; 84: 146-155.
15. Yasuoka H, Yoshizumi M, Inui D, et al: Effect of endothelin-1 (1-31) on intracellular free calcium in cultured human mesangial cells. Life Sci 1999; 65: PL267-PL272.
16. Ozawa Y, Hasegawa T, Tsuchiya K, Yoshizumi M, Tamaki T: Effect of endothelin- 1 (1-31) on the renal resistance vessels. J Med Invest 2003; 50: 87-94.
17. Kitamura A, Kagami S, Urushihara M, et al: Endothelin-1 is a potent stimulator of alpha1beta1 integrin-mediated collagen matrix remodeling by rat mesangial cells. Biochem Biophys Res Commun 2002; 299: 555-561.
18. Van Goor H, Ding G, Kees-Folts D, Grond J, Schreiner GF, Diamond JR: Macrophages and renal disease. Lab Invest 1994; 71: 456-464.
19. Yang N, Isbel NM, Nikolic-Paterson DJ, et al: Local macrophage proliferation in human glomerulonephritis. Kidney Int 1998; 54: 143-151.
20. Forbes JM, Leaker B, Hewitson TD, Becker GJ, Jones CL: Macrophage and myofibroblast involvement in ischemic acute renal failure is attenuated by endothelin receptor antagonists. Kidney Int 1999; 55: 198-208.
21. Kagami S, Border WA, Miller DE, Noble NA: Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells. J Clin Invest 1994; 93: 2431-2437.
22. Tsuchiya S, Yamabe M, Yamaguchi Y, Kobayashi Y, Konno T, Tada K: Establishment and characterization of a human acute monocytic leukemia cell line (THP-1). Int J Cancer 1980; 26: 171-176.
23. Keely PJ, Fong AM, Zutter MM, Santoro SA: Alteration of collagen-dependent adhesion, motility, and morphogenesis by the expression of antisense alpha 2 integrin mRNA in mammary cells. J Cell Sci 1995; 108: 595-607.
24. Okada M, Suzuki A, Mizuno K, et al: Effects of 17 beta-estradiol and progesterone on migration of human monocytic THP-1 cells stimulated by minimally oxidized low-density lipoprotein in vitro. Cardiovasc Res 1997; 34: 529-535.
25. Falk W, Goodwin RH Jr, Leonard EJ: A 48-well micro chemotaxis assembly for rapid and accurate measurement of leukocyte migration. J Immunol Methods 1980; 33: 239-247.
26. Yoshizumi M, Abe J, Haendeler J, Huang Q, Berk BC: Src and Cas mediate JNK activation but not ERK1/2 and p38 kinases by reactive oxygen species. J Biol Chem 2000; 275: 11706-11712.
27. Watanabe H, Miyazaki H, Kondoh M, et al: Two distinct types of endothelin receptors are present on chick cardiac membranes. Biochem Biophys Res Commun 1989; 161: 1252-1259.
28. Ihara M, Noguchi K, Saeki T, et al: Biological profiles of highly potent novel endothelin antagonists selective for the ETA receptor. Life Sci 1992; 50: 247-255.
29. Ishikawa K, Ihara M, Noguchi K, et al: Biochemical and pharmacological profile of a potent and selective endothelin B-receptor antagonist, BQ-788. Proc Natl Acad Sci USA 1994;91:4892-4896.
30. Matsumura Y, Ikegawa R, Tsukahara. Y, Takaoka M, Morimoto S: Conversion of big endothelin-1 to endothelin-1 by two-types of metalloproteinases of cultured porcine vascular smooth muscle cells. Biochem Biophys Res Commun 1991; 178: 899-905.
31. Yoshimura T, Robinson EA, Tanaka S, Appella E, Leonard EJ: Purification and amino acid analysis of two human monocyte chemoattractants produced by phytohemagglutinin-stimulated human blood mononuclear leukocytes. J Immunol 1989; 142: 1956-1962.
32. Leonard EJ, Yoshimura T: Human monocyte chemoattractant protein-1 (MCP-1). Immunol Today 1990; 11: 97-101.
33. Segerer S, Nelson PJ, Schlondorff D: Chemokines, chemokine receptors, and renal disease: from basic science to pathophysiologic and therapeutic studies. J Am Soc Nephrol 2000; 11: 152-176.
34. 2+]i in human coronary artery smooth muscle cells. Eur J Pharmacol 1998; 348: 305-309.
35. Suzaki Y, Yoshizumi M, Yamashita Y, et al: Determination of plasma concentrations of endothelin-1(1-31) and endothelin-1 in healthy subjects and patients with atherosclerosis. J Cardiovasc Pharmacol 2003; 41(Suppl 1): S83-S87.
36. Herman WH, Emancipator SN, Rhoten RL, Simonson MS: Vascular and glomerular expression of endothelin-1 in normal human kidney. Am J Physiol 1998; 275: F8-F17.
37. Klahr S, Schreiner G, Ichikawa I: The progression of renal disease. N Engl J Med 1988; 318: 1657-1666.
38. Schreiner GF, Cotran RS, Pardo V, Unanue ER: A mononuclear cell component in experimental immunological glomerulonephritis. J Exp Med 1978; 147: 369-384.
39. Monga G, Mazzucco G, di Belgicjoso GB, Busnach G: Monocyte infiltration and glomerular hypercellularity in human acute and persistent glomerulonephritis: light and electron microscopic, immunofluorescence, and histochemical investigation on twenty-eight cases. Lab Invest 1981; 44: 381-387.
40. Ferrario F, Castiglione A, Colasanti G, Barbiano di Belgioioso G, Bertoli S, D'Amico G: The detection of monocytes in human glomerulonephritis. Kidney Int 1985; 28: 513-519.
41. Schreiner GF: The role of the macrophage in glomerular injury. Semin Nephrol 1991; 11: 268-275.
42. Schreiner GF: The mesangial phagocyte and its regulation of contractile cell biology. J Am Soc Nephrol 1992; 2: S74-S82.
43. Floege J, Alpers CE, Burns MW, et al: Glomerular cells, extracellular matrix accumulation, and the development of glomerulosclerosis in the remnant kidney model. Lab Invest 1992; 66: 485-497.
44. Grimshaw MJ, Wilson JL, Balkwill FR: Endothelin-2 is a macrophage chemoattractant: implications for macrophage distribution in tumors. Eur J Immunol 2002; 32: 2393-2400.
45. Schlondorff D: The role of chemokines in the initiation and progression of renal disease. Kidney Int 1995; 49(Suppl): S44-S47.
46. Panzer U, Stahl RA: Chemokines and renal inflammation. Nephrologie 1999; 20: 335-341.
47. Rovin BH: Chemokine blockade as a therapy for renal disease. Curr Opin Nephrol Hypertens 2000; 9: 225-232.
48. Satriano JA, Hora K, Shan Z, Stanley ER, Mori T, Schlondorff D: Regulation of monocyte chemoattractant protein-1 and macrophage colony-stimulating factor-1 by IFN-gamma, tumor necrosis factor-alpha, IgG aggregates, and cAMP in mouse mesangial cells. J Immunol 1993; 150: 1971-1978.
49. Hora K, Satriano JA, Santiago A, et al: Receptors for IgG complexes activate synthesis of monocyte chemoattractant peptide 1 and colony- stimulating factor 1. Proc Natl Acad Sci USA 1992; 89: 1745-1749.
50. Schmouder RL, Strieter RM, Kunkel SL: Interferon-gamma regulation of human renal cortical epithelial cell-derived monocyte chemotactic peptide-1. Kidney Int 1993; 44: 43-49.
51. Gonzalez-Cuadrado S, Bustos C, Ruiz-Ortega M, et al: Expression of leucocyte chemoattractants by interstitial renal fibroblasts: up-regulation by drugs associated with interstitial fibrosis. Clin Exp Immunol 1996; 106: 518-522.
52. Prodjosudjadi W, Gerritsma JS, van Es LA, Daha MR, Bruijn JA: Monocyte chemoattractant protein-1 in normal and diseased human kidneys: an immunohistochemical analysis. Clin Nephrol 1995; 44: 148-155.